Wesbanco Bank Inc. Has $1.16 Million Stock Holdings in Phreesia, Inc. (NYSE:PHR)

Wesbanco Bank Inc. grew its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 76.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 46,000 shares of the company's stock after buying an additional 20,000 shares during the quarter. Wesbanco Bank Inc. owned 0.08% of Phreesia worth $1,157,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Versor Investments LP acquired a new position in shares of Phreesia during the 3rd quarter worth about $694,000. Zacks Investment Management purchased a new stake in shares of Phreesia during the third quarter worth approximately $631,000. Sei Investments Co. raised its stake in Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company's stock valued at $3,505,000 after purchasing an additional 95,058 shares during the last quarter. State Street Corp boosted its stake in Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company's stock worth $30,256,000 after purchasing an additional 88,517 shares during the last quarter. Finally, Barclays PLC raised its position in shares of Phreesia by 83.6% in the third quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after buying an additional 43,225 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Price Performance

PHR traded up $0.70 during trading on Friday, reaching $27.98. The stock had a trading volume of 179,383 shares, compared to its average volume of 367,269. The stock has a 50 day moving average of $24.00 and a two-hundred day moving average of $23.00. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of -19.01 and a beta of 0.94. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16.

Phreesia (NYSE:PHR - Get Free Report) last released its earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business's revenue for the quarter was up 16.6% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.58) EPS. As a group, equities analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Insider Buying and Selling at Phreesia

In other Phreesia news, SVP Amy Beth Vanduyn sold 25,447 shares of the firm's stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $20.93, for a total transaction of $532,605.71. Following the transaction, the senior vice president now directly owns 93,470 shares in the company, valued at $1,956,327.10. This trade represents a 21.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Balaji Gandhi sold 3,195 shares of the business's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $85,018.95. Following the completion of the sale, the chief financial officer now directly owns 148,509 shares of the company's stock, valued at $3,951,824.49. This represents a 2.11 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 131,756 shares of company stock worth $3,244,909. 5.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Truist Financial raised their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a research note on Wednesday, December 11th. Royal Bank of Canada upgraded Phreesia from a "sector perform" rating to an "outperform" rating and boosted their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. KeyCorp boosted their price target on shares of Phreesia from $28.00 to $30.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 8th. Robert W. Baird dropped their price target on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a research note on Wednesday, December 11th. Finally, Citigroup boosted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia has a consensus rating of "Buy" and a consensus price target of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.